IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Chile

  • ID: 1408477
  • Report
  • Region: Chile
  • 44 Pages
  • IMS Health
1 of 3

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Note: Product cover images may vary from those shown
2 of 3

1. Healthcare System

  • Facts & Figures
  • Market Indicators
  • Provision & Funding
  • Public Sector
  • Private Sector
  • Other Sectors
  • Reforms

2. Pricing

  • Prescription Drugs
  • CENABAST
  • Private Sector
  • Commission to Investigate Drug Pricing and Access
  • Generic Drugs
  • Hospital Drugs
  • OTC Drugs

3. Reimbursement

  • Admission to Reimbursement
  • Explicit Health Guarantees Scheme
  • Financial Protection System for High-cost Diagnostics and Treatments
  • Public Sector
  • Private Sector
  • Reimbursement Categories
  • Reimbursement Prices
  • Hospital Reimbursement
  • Public Sector
  • Private Sector
  • Changes in Reimbursement Status
  • Explicit Health Guarantees Scheme
  • Financial Protection System for High-cost Diagnostics and Treatments
  • Changes in Reimbursement Prices

4. Pharmacoeconomics

  • Pharmacoeconomic Requirements
  • ETESA
  • Private Payers

5. Price Build Up

  • Wholesalers
  • Pharmacy Chains
  • Independent Pharmacies
  • Retail Pharmacies
  • Public Sector
  • Private Sector
  • Dispensing Doctors
  • Sales Tax

6. Cost Containment

  • Industry Paybacks
  • Promotional Costs
  • Patient Co-payments
  • Public Sector
  • Private Sector
  • Catastrophic Health Insurance
  • Prescribing Controls
  • Formularies
  • Generics
  • Generics
  • Generic Substitution
  • INN Prescribing
  • Bioequivalence Requirements
  • Intellectual Property
  • Rx-to-OTC Switches
  • Switches
  • OTC Market
  • Parallel Trade

7. Future Developments

  • Outlook
  • Reform of Private Insurance Sector
  • Medicines Law II
  • National Investment Plan
  • Expansion of Reimbursement

8. Names & Addresses

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll